Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study

dc.contributor.author	Özgün, M. A.
dc.contributor.author	Doğan, I.
dc.contributor.author	Karakurt Eryılmaz, Melek
dc.contributor.author	Erdoğan, A. P.
dc.contributor.author	Ayhan, M.
dc.contributor.author	Hafızoğlu, E.
dc.contributor.author	Laçin, S.
dc.contributor.author	Çavdar, Eyyüp
dc.date.accessioned	2022-05-11T14:40:56Z
dc.date.available	2022-05-11T14:40:56Z
dc.date.issued	2021
dc.identifier.issn	0923-7534
dc.identifier.issn	1569-8041
dc.identifier.uri	https://doi.org/10.1016/j.annonc.2021.08.1461
dc.identifier.uri	https://hdl.handle.net/20.500.11776/8985
dc.description.abstract	[No Abstract Available]	en_US
dc.language.iso	eng	en_US
dc.publisher	Elsevier	en_US
dc.identifier.doi	10.1016/j.annonc.2021.08.1461
dc.rights	info:eu-repo/semantics/openAccess	en_US
dc.title	Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study	en_US
dc.type	meetingAbstract	en_US
dc.relation.ispartof	Annals of Oncology	en_US
dc.department	Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Ana Bilim Dalı	en_US
dc.authorid	0000-0003-1018-1119
dc.identifier.volume	32	en_US
dc.identifier.startpage	S892	en_US
dc.identifier.endpage	S892	en_US
dc.institutionauthor	Çavdar, Eyyüp
dc.relation.publicationcategory	Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı	en_US
dc.authorwosid	dogan, izzet/AAB-6635-2020
dc.identifier.wos	WOS:000700527702094	en_US